AT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
More Information Supplier PageAT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
More Information Supplier PageAT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
More Information Supplier PageAT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
More Information Supplier PageASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
More Information Supplier PageASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
More Information Supplier PageASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
More Information Supplier PageAvibactam is a covalent, reversible, non-??-lactam ??-lactamase inhibitor.
More Information Supplier PageAvibactam is a covalent, reversible, non-??-lactam ??-lactamase inhibitor.
More Information Supplier PageAvibactam is a covalent, reversible, non-??-lactam ??-lactamase inhibitor.
More Information Supplier Page
